Tissue distribution of gold and silver after subacute intravenous injection of co-administered gold and silver nanoparticles of similar sizes

  • Ji Hyun Lee
  • Jae Hyuck Sung
  • Hyun Ryol Ryu
  • Kyung Seuk Song
  • Nam Woong Song
  • Hyun Min Park
  • Beom Soo Shin
  • Kangho Ahn
  • Mary Gulumian
  • Elaine M. Faustman
  • Il Je Yu
Inorganic Compounds
  • 31 Downloads

Abstract

Gold (AuNPs, 12.8 nm) and silver nanoparticles (AgNPs, 10 nm), mixed or separate, were injected into the caudal vein of male Sprague–Dawley rats for 4 weeks. The rats were allowed to recover for further 4 weeks to examine the differences in AuNP/AgNP tissue distribution and clearance. The size distribution of injected AuNPs and AgNPs were not statistically different. The dose groups (five males per group for the administration and three males for the recovery) consisted of seven divisions, i.e., control, AgNPs (with a low dose of 10 µg/kg/day, and, a high dose of 100 µg/kg/day), AuNPs (with a low dose of 10 µg/kg/day, and, a high dose of 100 µg/kg/day), as well as mixed AgNPs/AuNPs (with a low dose of 10/10 µg/kg/day, and a high dose of 100/100 µg/kg/day). The AgNPs accumulated in a dose-dependent manner in the liver, spleen, kidneys, lung, brain, testis or blood. Au concentration increased also in a dose-dependent manner in the liver, kidneys, spleen and lungs, but not in the brain, testis and blood. Ag concentration in the tissues increased dose-dependently after 4 weeks of AgNP/AuNP mixed administration, but to a much lower extent than those observed when they were administered separately. Ag concentration in the tissues after 4 weeks of AgNP/AuNP mixed administration cleared dose-dependently after 4 weeks of recovery. Au concentration in the tissues increased dose-dependently after 4 weeks of AgNp/AuNP mixed administration, while Au concentration in the tissues did not clear as seen in Ag after 4 weeks recovery. Au concentration showed biopersistency or accumulation in the liver, kidneys, spleen and brain of the 4 weeks of recovery. In conclusion, AgNPs and AuNPs showed different toxicokinetic properties and the mixed administration of AgNPs with AuNPs resulted in mutual reduction of their tissue distribution which appeared to be due to competitive inhibition. Furthermore, this subacute intravenous injection study has suggested that these nanoparticles were distributed to the organs in particulate instead of ionic forms.

Keywords

Silver nanoparticles Gold nanoparticles Subacute intraveneous injection Co-administration Tissue distribution Toxicokinetics 

Notes

Acknowledgements

This research was supported by the NanoMaterial Technology Development Program (2014M3A7B6020163) through the National Research Foundation of Korea (NRF) funded by the Korean Ministry of Science, ICT and Future Planning, and the Industrial Technology Innovation Program (1005291, Development of highly usable nanomaterial inhalation toxicity testing system in commerce) through the Korea Evaluation Institute of Industrial Technology by the Korean Ministry of Trade, Industry & Energy and NIH/NIEHS Grants U19ES019545, P30ES007033 and EPA Grant RD83573801.

Compliance with ethical standards

Conflict of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Supplementary material

204_2018_2173_MOESM1_ESM.doc (576 kb)
Supplementary material 1 (DOC 576 KB)

References

  1. Abdelhalim MAK, Mady MM (2011) Liver uptake of gold nanoparticles after intraperitoneal administration in vivo: a fluorescence study. Lipids Health Dis 10:195CrossRefPubMedPubMedCentralGoogle Scholar
  2. Balasubramanian SK, Jittiwat J, Manikandan J, Ong CN, Yu LE, Ong WY (2010) Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials 31:2034–2042CrossRefPubMedGoogle Scholar
  3. Cho WS, Cho M, Jeong J, Choi M, Han BS, Shin HS, Hong J, Chung BH, Joen J, Cho MH (2010) Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 245:116–123CrossRefPubMedGoogle Scholar
  4. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE (2008) Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29:1912–1919CrossRefPubMedGoogle Scholar
  5. Han SG, Lee JS, Ahn K, Kim YS, Kim JK, Lee JH, Shin JH, Jeon KS, Cho WS, Song NW, Gulumian M, Shin BS, Yu IJ (2015) Size‑dependent clearance of gold nanoparticles from lungs of Sprague–Dawley rats after short‑term inhalation exposure. Arch Toxicol 89(7):1083–1094CrossRefPubMedGoogle Scholar
  6. Hillyer JF, Algrecht RM (2001) Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharmaceutical Sciences 90(12):1927–1936CrossRefGoogle Scholar
  7. Hocherl A, Dass M, Landfester K, Mailander V, Musyanovych A (2012) Competitive cellular uptake of nanoparticles made from polystyrene, poly(methyl methacrylate), and polylactide. Macromol Biosci 12(4):454–464CrossRefPubMedGoogle Scholar
  8. Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, Chung YH, Kwon IH, Jeong J, Han BS. Shin JH, Sung KH, Song KS, Yu IJ (2007) Twenty eight-days inhalation toxicity study of silver nanoparticles in Sprague–Dawley Rats. Inhal Toxicol 19:857–871CrossRefPubMedGoogle Scholar
  9. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu IJ (2008) Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague–Dawley rats. Inhal Toxicol 20:575–583CrossRefPubMedGoogle Scholar
  10. Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, Chang HK, Lee JH, Oh KH, Kelman BJ, Hwang IK, Yu IJ (2010) Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol 7:20CrossRefPubMedPubMedCentralGoogle Scholar
  11. Lankveld DP, Oomen AG, Krystek P, Neigh A, Troost-de Jong A, Noorlander CW, Van Eijkeren JC, Geertsma RE, De Jong WH (2010) The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31:8350–8361CrossRefPubMedGoogle Scholar
  12. Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, Olmedo I, Clos A, Ramanujam VSM et al (2010) Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun 393(4):649–655CrossRefPubMedGoogle Scholar
  13. Lee JH, Kwon M, Ji JH, Kang CS, Ahn KH, Han JH, Yu IJ (2011) Exposure assessment of workplaces manufacturing nanosized TiO2 and silver. Inhal Toxicol 23:226–236CrossRefPubMedGoogle Scholar
  14. Lee JH, Kim YS, Song KS, Ryu HR, Sung JH, Park JD, Park HM, Song NW, Shin BS, Marshak D, Ahn K, Lee HE, Yu IJ (2013) Biopersistence of silver nanoparticles in tissues from Sprague–Dawley rats. Part Fibre Toxicol 10:36CrossRefPubMedPubMedCentralGoogle Scholar
  15. Liu J, Zhongying W, Liu FD, Kane AB, Hurt RH (2012) Chemical transformations of nanosilver in biological environments. ACS Nano 6(11):9887–9899CrossRefPubMedPubMedCentralGoogle Scholar
  16. NIOSH (1994) NIOSH manual of analytical methods (NMAM): Method No. 7402. Asbestos by TEM, 4th edn. National Institute for Occupational Safety and Health, Cincinnati, pp 2–7Google Scholar
  17. NIOSH (2003) NIOSH manual of analytical methods (NMAM): Method No. 7300. Elements by ICP (Nitric/Perchloric Acid Ashing), 4th edn. National Institute for Occupational Safety and Health, Cincinnati, pp 2–8Google Scholar
  18. Oberdörster G. Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):823–839CrossRefPubMedPubMedCentralGoogle Scholar
  19. Organization for Economic Cooperation and Development (OECD) (2010) OECD guidelines for the testing of chemicals. Test Guideline 417. Toxicokinetics. OECD, ParisGoogle Scholar
  20. Organization for Economic Cooperation and Development (OECD) (2015a) Series on the safety of manufactured nanomaterials No. 53. Dossier on silver nanoparticles, Part 1. OECD, ParisGoogle Scholar
  21. Organization for Economic Cooperation and Development (OECD) (2015b) Series on the safety of manufactured nanomaterials No. 44. Dossier on gold nanoparticles. OECD, ParisGoogle Scholar
  22. Sadauskas E, Jacobsen RJ, Danscher G, Stoltenberg M, Vogel U, Larsen A, Kreyling W, Wallin H (2009) Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation. Chem Cent J 3:16CrossRefPubMedPubMedCentralGoogle Scholar
  23. Sonavane G, Tomoda K, Makino K (2008) Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf 66:264–280Google Scholar
  24. Song KS, Sung JH, Ji JH, Lee JH, Lee JS, Ryu HR, Lee JK, Chung YH, Park HM, Shin BS, Chang HK, Kelman BJ, Yu IJ (2013) Recovery from silver-nanoparticle-exposure-induced lung inflammation and lung function changes in Sprague Dawley rats. Nanotoxicology 7(2):169–180CrossRefPubMedGoogle Scholar
  25. Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Chang HK, Lee JH, Cho MH, Kelman BJ, Yu IJ (2009) Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 108:452–461CrossRefPubMedGoogle Scholar
  26. Sung JH, Ji JH, Park JD, Song MY, Song KS, Ryu HR, Yoon JU, Jeon KS, Jeong J, Han BS, Chung YH, Chang HK, Lee JH, Kim DW, Kelman BJ, Yu IJ (2011) Subchronic inhalation toxicity of gold nanoparticles. Part Fibre Toxicol 8:16CrossRefPubMedPubMedCentralGoogle Scholar
  27. Takenaka S, Karg E, Kreyling WG, Lentner B, Möller W, Behnke-Semmler M, Jennen l, Walch A, Michalke B, Schramel P, Heyder J, Schulz H (2006) Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhalation Toxicol 18:733–740CrossRefGoogle Scholar
  28. Troy DB, Beringer P (2006) Remington: the science and practice of pharmacy 21st, 21 edn. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  29. van der Zande M, Vandebriel RJ, Van Doren E, Kramer E, Herrera Rivera Z, Serrano-Rojero CS, Gremmer ER, Mast J, Peters RJ, Hollman PC, Hendriksen PJ, Marvin HJ, Peijnenburg AA, Bouwmeester H (2012) Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 6(8):7427–7442CrossRefPubMedGoogle Scholar
  30. Voigt J, Christensen J, Shastri VP (2014) Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae. Proc Natl Acad Sci USA 111(8):2942–2947CrossRefPubMedPubMedCentralGoogle Scholar
  31. Wojnicki M, Luty-Blocho M. Bednarski M, Dudek M, Knutelska J, Sapa J, Zygmunt M, Nowa G, Fitzner K (2013) Tissue distribution of gold nanoparticles after single intravenous administration in mice. Pharmacol Rep 65:1033–1038CrossRefPubMedGoogle Scholar
  32. Yu LE, Yung LYK, Ong CN, Tan YL, Balasubramaniam KS, Hartono D, Shui G, Wenk MR, Ong WY (2007) Translocation and effects of gold nanoparticles after inhalation exposure in rats. Nanotoxicology 1(3):235–242CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Ji Hyun Lee
    • 1
  • Jae Hyuck Sung
    • 2
  • Hyun Ryol Ryu
    • 2
  • Kyung Seuk Song
    • 2
  • Nam Woong Song
    • 3
  • Hyun Min Park
    • 3
  • Beom Soo Shin
    • 4
  • Kangho Ahn
    • 5
  • Mary Gulumian
    • 6
    • 7
  • Elaine M. Faustman
    • 1
  • Il Je Yu
    • 8
  1. 1.Institute for Risk Analysis and Risk Communication, Department of Environmental and Occupational Health SciencesUniversity of WashingtonSeattleUSA
  2. 2.Korea Conformity LaboratoriesIncheonKorea
  3. 3.Korea Research Institute of Standards and ScienceDaejeonKorea
  4. 4.School of PharmacySungkyunkwan UniversitySuwonKorea
  5. 5.Department of Mechanical EngineeringHanyang UniversityAnsanKorea
  6. 6.National Institute for Occupational HealthJohannesburgSouth Africa
  7. 7.Haematology and Molecular MedicineUniversity of the WitwatersrandJohannesburgSouth Africa
  8. 8.HCTm CO., LTDIcheonRepublic of Korea

Personalised recommendations